top of page
The Professional Network for Healthcare Experts
China NMPA approves Foresee's Camcevi 42 mg six-month injection for advanced prostate cancer
China's NMPA has approved Foresee Pharmaceuticals' Camcevi 42 mg, a ready-to-use six-month leuprolide injection for adults with advanced prostate cancer.
nuaxia
22 hours ago2 min read
FDA approves Teva's Weltruza as first once-monthly subcutaneous olanzapine injection for schizophrenia
Teva has secured FDA approval for Weltruza, the first once-monthly subcutaneous extended-release olanzapine injection for adults with schizophrenia.
nuaxia
2 days ago2 min read
bottom of page